课题基金 / 基金详情

7th ASM Conference on Candida and Candidiasis

7th ASM Conference on Candida and Candidiasis
第七届 ASM 念珠菌和念珠菌病会议
批准号:
6770757
负责人:
Welda LaJean CHAFFIN
金额:
$1.0万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-03-01 至 2005-02-28

项目摘要

项目成果

Welda LaJean CHAFFIN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):白色念珠菌是一种寄生于皮肤和粘膜表面的共生菌。它也是这些表面的机会性疾病以及内部播散性疾病的媒介。虽然皮肤和粘膜表面感染可能是显著发病率的原因,每年影响数百万美国人,但它们并不像播散性疾病那样危及生命。在20世纪80年代中期,越来越多的研究人员被疾病发病机理的研究所吸引。为了响应该小组之间交流思想的需要,1987年举行了第一次关于念珠菌和念珠菌病的ASM会议,出席人数约为115人。从那时起,不仅研究人员的数量增加了,而且患病患者的数量也增加了。不幸的是,口腔黏膜疾病几乎是艾滋病的普遍并发症,而念珠菌现在已成为院内血流感染的第四大原因。近年来,出现了抗唑菌株和非白色念珠菌分离株的频率增加,特别是那些固有的耐药菌株。
英文摘要
DESCRIPTION (provided by applicant): Candida albicans is a commensal that colonizes skin and mucosal surfaces. It is also an agent of opportunistic disease of these surfaces as well as internal disseminated disease. While infections of cutaneous and mucosal surfaces may be a cause of significant morbidity and affect millions of Americans annually, they are not life threatening as is disseminated disease. In the mid-1980's a growing number of researchers were attracted to the study of pathogenesis of disease. In response to the need for exchange of ideas among this group, the first ASM Conference on Candida and Candidiasis was held in 1987 with an attendance of about 115. Since this time not only have the number of researchers grown but so have the number of patients with disease. Oral mucosal disease is unfortunately a nearly universal complication of AIDS and Candida has now become the fourth leading cause of nosocomial blood stream infections. In recent years there has been an emergence of azole resistant strains and increased frequency of non-albicans isolates, particularly those that are inherently drug resistant. This conference has been held every three years and is the premier forum for researchers engaged in study of the biology, epidemiology, and pathogenesis of candidal infection. However, at the 6th Conference in 2002 a large majority voted that the meeting by placed on a two-year schedule. Accordingly, the 7th Conference will be held March 24-28, 2004 at the Hyatt Regency in Austin, Texas. The goal of the 7th Conference is to continue to provide the forum to present the state of the art research and for investigators to meet and discuss their work informally. This 7th Conference is expected to have an attendance of 300 - 400 and the presentation of 150-200 posters. The topics that will be covered in the oral and/or poster sessions include: 1) mating and genetics, 2) epidemiology and population studies, 3) signaling and morphogenesis, 4) biofilms and pathogen interactions 5) genomics and proteomics, 6) drugs and resistance, 7) cell wall and surface molecules, 8) diagnosis and treatment, and 9) host response. Speakers and attendees are expected to represent the international community of Candida researchers with both established and new investigators as well as students and trainees present. Many of the speakers, in addition to at least 12 graduate students and postdoctoral associates, will be selected from abstracts. NIH through various institutes and programs has generously supported many of the American presenters and attendees of this conference, as well as the previous two conferences and it is hoped that NIH will join ASM and private sources in providing financial assistance for this upcoming 7th Conference in 2004.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Candida albicans-specific mucosal CD4+ T cell clones
A proteomics approach to Candida albicans biofilm
A proteomics approach to Candida albicans biofilm
A proteomics approach to Candida albicans biofilm
海外基金